Research shows clopidogrel as better long-term therapy than aspirin after PCI - report from ACC.25

Joo-Yong Hahn shares his insights on the research presented at the American College of Cardiology's Annual Scientific Session. People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel rather than aspirin as their long-term antiplatelet therapy, according to Research. Video: https://medicaldigest.org/scientific-contents/interview:research-shows-clopidogrel-better-long-term-therapy-aspirin-after-pci-report-acc25